Regorafenib induces apoptosis and inhibits metastatic potential of human bladder carcinoma cells

Fei Ting Hsu, Cho Chin Sun, Chia Hsing Wu, Yen Ju Lee, Chih Hung Chiang, Wei Shu Wang

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The aim of the present study was to verify the effects of regorafenib on apoptosis and metastatic potential in TSGH 8301 human bladder carcinoma cells in vitro. Cells were treated with different concentration of regorafenib for different periods of time. Effects of regorafenib on cell viability, apoptosis pathways, metastatic potential, and expression of metastatic and anti-apoptotic proteins were evaluated with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assay, flow cytometry, cell migration and invasion assay, and western blotting. We found regorafenib significantly reduced cell viability, cell migration and invasion, and expression of metastatic and anti-apoptotic proteins. In addition, regorafenib significantly induced accumulation of sub-G1 phase cells, loss of mitochondrial membrane potential, and expression of active caspase-3 and caspase-8. These results show that regorafenib not only induces apoptosis, but also inhibits metastatic potential in bladder cancer TSGH 8301 cells in vitro.

Original languageEnglish
Pages (from-to)4919-4926
Number of pages8
JournalAnticancer Research
Volume37
Issue number9
DOIs
Publication statusPublished - Sep 1 2017

Fingerprint

Urinary Bladder
Apoptosis
Carcinoma
Apoptosis Regulatory Proteins
Cell Survival
Cell Migration Assays
Caspase 8
Mitochondrial Membrane Potential
G1 Phase
Urinary Bladder Neoplasms
Caspase 3
Cell Movement
regorafenib
Flow Cytometry
Western Blotting
In Vitro Techniques

Keywords

  • Apoptosis
  • Human bladder carcinoma
  • Metastatic potential
  • Regorafenib

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Hsu, F. T., Sun, C. C., Wu, C. H., Lee, Y. J., Chiang, C. H., & Wang, W. S. (2017). Regorafenib induces apoptosis and inhibits metastatic potential of human bladder carcinoma cells. Anticancer Research, 37(9), 4919-4926. https://doi.org/10.21873/anticanres.11901

Regorafenib induces apoptosis and inhibits metastatic potential of human bladder carcinoma cells. / Hsu, Fei Ting; Sun, Cho Chin; Wu, Chia Hsing; Lee, Yen Ju; Chiang, Chih Hung; Wang, Wei Shu.

In: Anticancer Research, Vol. 37, No. 9, 01.09.2017, p. 4919-4926.

Research output: Contribution to journalArticle

Hsu, Fei Ting ; Sun, Cho Chin ; Wu, Chia Hsing ; Lee, Yen Ju ; Chiang, Chih Hung ; Wang, Wei Shu. / Regorafenib induces apoptosis and inhibits metastatic potential of human bladder carcinoma cells. In: Anticancer Research. 2017 ; Vol. 37, No. 9. pp. 4919-4926.
@article{f7ed4915d0874b098a1e85fff7e6cc73,
title = "Regorafenib induces apoptosis and inhibits metastatic potential of human bladder carcinoma cells",
abstract = "The aim of the present study was to verify the effects of regorafenib on apoptosis and metastatic potential in TSGH 8301 human bladder carcinoma cells in vitro. Cells were treated with different concentration of regorafenib for different periods of time. Effects of regorafenib on cell viability, apoptosis pathways, metastatic potential, and expression of metastatic and anti-apoptotic proteins were evaluated with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assay, flow cytometry, cell migration and invasion assay, and western blotting. We found regorafenib significantly reduced cell viability, cell migration and invasion, and expression of metastatic and anti-apoptotic proteins. In addition, regorafenib significantly induced accumulation of sub-G1 phase cells, loss of mitochondrial membrane potential, and expression of active caspase-3 and caspase-8. These results show that regorafenib not only induces apoptosis, but also inhibits metastatic potential in bladder cancer TSGH 8301 cells in vitro.",
keywords = "Apoptosis, Human bladder carcinoma, Metastatic potential, Regorafenib",
author = "Hsu, {Fei Ting} and Sun, {Cho Chin} and Wu, {Chia Hsing} and Lee, {Yen Ju} and Chiang, {Chih Hung} and Wang, {Wei Shu}",
year = "2017",
month = "9",
day = "1",
doi = "10.21873/anticanres.11901",
language = "English",
volume = "37",
pages = "4919--4926",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "9",

}

TY - JOUR

T1 - Regorafenib induces apoptosis and inhibits metastatic potential of human bladder carcinoma cells

AU - Hsu, Fei Ting

AU - Sun, Cho Chin

AU - Wu, Chia Hsing

AU - Lee, Yen Ju

AU - Chiang, Chih Hung

AU - Wang, Wei Shu

PY - 2017/9/1

Y1 - 2017/9/1

N2 - The aim of the present study was to verify the effects of regorafenib on apoptosis and metastatic potential in TSGH 8301 human bladder carcinoma cells in vitro. Cells were treated with different concentration of regorafenib for different periods of time. Effects of regorafenib on cell viability, apoptosis pathways, metastatic potential, and expression of metastatic and anti-apoptotic proteins were evaluated with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assay, flow cytometry, cell migration and invasion assay, and western blotting. We found regorafenib significantly reduced cell viability, cell migration and invasion, and expression of metastatic and anti-apoptotic proteins. In addition, regorafenib significantly induced accumulation of sub-G1 phase cells, loss of mitochondrial membrane potential, and expression of active caspase-3 and caspase-8. These results show that regorafenib not only induces apoptosis, but also inhibits metastatic potential in bladder cancer TSGH 8301 cells in vitro.

AB - The aim of the present study was to verify the effects of regorafenib on apoptosis and metastatic potential in TSGH 8301 human bladder carcinoma cells in vitro. Cells were treated with different concentration of regorafenib for different periods of time. Effects of regorafenib on cell viability, apoptosis pathways, metastatic potential, and expression of metastatic and anti-apoptotic proteins were evaluated with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assay, flow cytometry, cell migration and invasion assay, and western blotting. We found regorafenib significantly reduced cell viability, cell migration and invasion, and expression of metastatic and anti-apoptotic proteins. In addition, regorafenib significantly induced accumulation of sub-G1 phase cells, loss of mitochondrial membrane potential, and expression of active caspase-3 and caspase-8. These results show that regorafenib not only induces apoptosis, but also inhibits metastatic potential in bladder cancer TSGH 8301 cells in vitro.

KW - Apoptosis

KW - Human bladder carcinoma

KW - Metastatic potential

KW - Regorafenib

UR - http://www.scopus.com/inward/record.url?scp=85029439691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029439691&partnerID=8YFLogxK

U2 - 10.21873/anticanres.11901

DO - 10.21873/anticanres.11901

M3 - Article

VL - 37

SP - 4919

EP - 4926

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 9

ER -